Today News Africa
  • Top Stories
  • Presidents
  • United States
  • White House
  • Economy
  • Health
  • More
    • Human Rights
    • African Ambassadors to U.S.
    • U.S. Ambassadors to Africa
    • African Women
    • African Men
    • Expert opinion
    • China
  • Web services
No Result
View All Result
  • Login
  • Register
Watch TV
Subscribe
Donate
Today News Africa
  • Top Stories
  • Presidents
  • United States
  • White House
  • Economy
  • Health
  • More
    • Human Rights
    • African Ambassadors to U.S.
    • U.S. Ambassadors to Africa
    • African Women
    • African Men
    • Expert opinion
    • China
  • Web services
No Result
View All Result
  • Login
  • Register
Watch TV
Subscribe
Donate
Today News Africa
No Result
View All Result
  • Login
Watch TV

Africa’s only COVID-19 vaccine production plant Aspen Pharmacare may have to shut down as no one wants to buy their Johnson & Johnson vaccine too risky to be used in the U.S. because of a dangerous clotting condition called ‘thrombosis’

Sarah Dwyer by Sarah Dwyer
May 9, 2022
A worker at the South African pharmaceutical major Aspen Pharmacare, is seen at its Johnson & Johnson COVID-19 vaccine facility in Gqeberha, South Africa, October 25, 2021. REUTERS/Siphiwe Sibeko

A worker at the South African pharmaceutical major Aspen Pharmacare, is seen at its Johnson & Johnson COVID-19 vaccine facility in Gqeberha, South Africa, October 25, 2021. REUTERS/Siphiwe Sibeko

509
SHARES
1.5k
VIEWS
Share on FacebookShare on TwitterShare on LinkedInShare on Reddit
Sarah Dwyer is an International Foreign Policy Correspondent for Today Africa News based in California. Sarah earned a bachelor’s degree in Journalism from San Jose State University. She focuses on COVID-19 relating to US-Africa ties.
Sarah Dwyer( Foreign Policy Correspondent )

Sarah Dwyer is an International Foreign Policy Correspondent for Today News Africa based in California. Sarah earned a bachelor’s degree in Journalism from San Jose State University. She focuses on COVID-19 relating to US-Africa ties.

Africa’s only COVID-19 vaccine production plant, Aspen Pharmacare, located in South Africa, may finally have to shut down as no one wants to buy their Johnson & Johnson vaccine which is no longer in use in the United States for people 18 years and older.

The latest blow for the company came from the World Health Organization and its COVID-19 partner Gavi who said they have no immediate plans to buy shots made by them, Reuters news agency reported on Monday.

Aspen finalized a deal to package, sell and distribute Johnson & Johnson vaccine expecting to be met with high demand, as the continent has less than 20% of the population fully vaccinated, according to Africa CDC.

But that optimism did not materialize. Orders did not come as anticipated and now the World Health Organization and Gavi have made it clear they do not intend to purchase doses as of now.

“In the case of Aspen, the current overall demand situation means we are currently not in a position to buy large quantities of vaccines,” a Gavi spokesperson said, according to Reuters.

The Global Vaccine Alliance, Gavi, is a public–private global health partnership with the goal of increasing access to immunization in poor countries.

FDA limits use of Johnson & Johnson vaccine in the United States:

Just last Thursday, the United States Food and Drug Administration (FDA) announced in a statement that it was limiting the emergency use authorization of the Johnson & Johnson/Jansen COVID-19 vaccine to people 18 and older. The FDA explained that the change was being made because of the risk of a rare and dangerous clotting condition called thrombosis with thrombocytopenia syndrome (TTS) after receiving the vaccine.

“We recognize that the Janssen COVID-19 Vaccine still has a role in the current pandemic response in the United States and across the global community. Our action reflects our updated analysis of the risk of TTS following administration of this vaccine and limits the use of the vaccine to certain individuals,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “Today’s action demonstrates the robustness of our safety surveillance systems and our commitment to ensuring that science and data guide our decisions. We’ve been closely monitoring the Janssen COVID-19 Vaccine and occurrence of TTS following its administration and have used updated information from our safety surveillance systems to revise the EUA. The agency will continue to monitor the safety of the Janssen COVID-19 Vaccine and all other vaccines, and as has been the case throughout the pandemic, will thoroughly evaluate new safety information.”

Competition with the world

Subscribe

Gain access to all our Premium contents.
More than 100+ articles.
Subscribe Now

About

  • Advertise with us
  • Corporate information
  • Compliance
  • Partners

News

  • Breaking News
  • Investigations
  • Special Segments
  • What’s hot?

Countries

  • Ethiopia
  • Nigeria
  • Angola
  • Cameroon
  • Ghana
  • South Africa
  • Kenya
  • Mozambique
  • Cape Verde
  • Zimbabwe
  • Eritrea
  • Others

TV

  • YouTube channel
  • Podcasts
  • Show
  • Show Clips
  • News Clips
  • Special Report

Politics

  • Politics
  • foreign Policy
  • The White House
  • The African Union
  • African Presidents
  • African Ambassadors in U.S

News

  • Breaking News
  • Investigations
  • Special Segments
  • What’s hot?

Health

  • Health
  • Coronavirus
  • Drug Manufacturers
  • WHO
  • Africa CDC
  • Top African Hospitals
  • Top African Doctors
  • Top African Scientists
  • African Healthcare

Business

  • Top Companies in Africa
  • Top African CEOs
  • Top American CEOs in Africa
  • African Entrepreneurs
  • Real Estate
  • Trade
  • IT
  • Top Stories
  • Presidents
  • United States
  • White House
  • Economy
  • Health
  • More
  • Web services

© Copyright 2022: All Rights Reserved | Today News Africa L.L.C. | Headquartered in Washington D.C.

No Result
View All Result
  • Top Stories
  • Presidents
  • United States
  • White House
  • Economy
  • Health
  • More
    • Human Rights
    • African Ambassadors to U.S.
    • U.S. Ambassadors to Africa
    • African Women
    • African Men
    • Expert opinion
    • China
  • Web services

© Copyright 2022: All Rights Reserved | Today News Africa L.L.C. | Headquartered in Washington D.C.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Today News Africa uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
error: Alert: Share This Content !!